Research Groups and R&D Platforms: In Vivo Diagnostics

Research Group:
Lyme borreliosis: A comprehensive approach

Jukka Hytönen
jukka.hytonen[at]utu.fi

Institute of Biomedicine,
University of Turku

Jukka Hytönen

Antibodies, Assay development, Bacteriology, Biomarker, Biomedicine, Clinical Medicine, Disease models, Epidemiology, Genomics, Imaging, Immunology, In Vitro Diagnostics, In Vivo Diagnostics, Infection, Inflammation, Molecular Biology, Molecular Cell Biology, Molecular diagnostics, PET, Point of care, X-ray crystallography

Picture of Eleanor Coffey

Research Group:
Kinase Function in Brain

Eleanor Coffey
eleanor.coffey[at]bioscience.fi

Turku Bioscience Centre,
Åbo Akademi University and University of Turku

Eleanor Coffey

Kinase Function in Brain

Ageing-related diseases, Basic research, Biomarker, Biomedicine, Data mining, Diagnostics, Disease models, Drug delivery, Drug target, In Vitro Diagnostics, In Vivo Diagnostics, Molecular Biology, Molecular diagnostics, Molecular modelling, Neurological disorders, PET, Proteomics, Screening, Signaling, Super-resolution imaging, Systems Biology, Target discovery

Research Group:
Exercise responses on non-skeletal metabolism

Jarna Hannukainen
jarna.hannukainen[at]tyks.fi

Turku PET Centre,
University or Turku

Jarna Hannukainen

Diabetes, Endocrinology, Imaging software, In Vivo Diagnostics, Metabolic diseases, Obesity, PET, Physiology, Ultrasound imaging

Research Group:
Bacterial infections: translational genomics, immunity and prevention

Qiushui He
Qiushui.He[at]utu.fi

Institute of Biomedicine,
University of Turku

Qiushui He

Allergy, Antibodies, Assay development, Bacteriology, Biomedicine, Epidemiology, Immunology, In Vitro Diagnostics, In Vivo Diagnostics, Infection, Inflammation, Molecular diagnostics, Nucleic acids

Picture of Hongbo Zhang

Research Group:
Functional Biomaterials & Microfluids

Hongbo Zhang
hongbo.zhang[at]abo.fi

Pharmaceutical Sciences Laboratory,
Åbo Akademi University

Hongbo Zhang

Structural Bioinformatics Laboratory

Precision Nanomedicine and Diagnostics

Atomic-force microscopy, Bioinformatics, Biomarker, Biomedicine, Cancer, Cardiovascular diseases, Data mining, Drug delivery, Drug solubility, Drug stability, Drug target, Electron microscopy, Fluorescence spectroscopy, FTIR or RAMAN spectroscopy, Genetics, Genomics, High throughput imaging, Imaging, Imaging software, In Vivo Diagnostics, Lead optimization, Molecular diagnostics, Nanoparticles, Next-generation sequencing, NMR, Nucleic acids, Organic compounds, Particle morphology, Particle size analysis, Personalized medicine, PET, Physico-chemical properties, Polymorph analysis, Porosity, Screening, Super-resolution imaging, Surface area, Synthetic chemistry, Target discovery, Thermal analysis, Ultrasound imaging, X-ray crystallography, Zeta potential

Research Group:
New tools to target harmful inflammations and cancer

Sirpa Jalkanen
sirjal[at]utu.fi

Institute of Biomedicine,
University of Turku

Sirpa Jalkanen

Cell Trafficking in Cancer and Inflammation

Ageing-related diseases, Antibodies, Autoimmune diseases, Basic research, Biochemistry, Biomarker, Biomedicine, Biopharmaceuticals, Breast cancer, Cancer, Cardiovascular diseases, Clinical Medicine, Colorectal cancer, Diagnostics, Disease models, Drug target, Imaging, Immunology, In Vitro Diagnostics, In Vivo Diagnostics, Inflammation, Lung cancer, Melanoma, Metabolic diseases, Molecular Cell Biology, Molecular diagnostics, Musculoskeletal disorders, Neurological disorders, Obesity, Ovarian cancer, Pathology, Personalized medicine, PET, Prostate cancer, Receptor, Signaling, Skin diseases, Squamous cell carcinoma, Target discovery